Delivery Order SPE2DB20D3101-SPE2DB23FRXA5

Award Date 9/8/23
Potential Completion Date 9/11/23
Potential Value $9.4K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of pharmaceutical products, including JANUVIA 100 MG TABLET 90S, to the Defense Logistics Agency (DLA) Troop Support Medical. The contract is a Delivery Order valued at $2,003.99 with a firm fixed price and a period of performance through November 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,578.56 for the supply of JANUVIA 50 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA) Troop Support Medical, a defense agency, and has a completion date of May 3, 2023. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026, which...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of JANUVIA 25 MG TABLET 90S, a pharmaceutical product, to support Defense Logistics Agency (DLA) Troop Support Medical. The award is a Delivery Order (DO) under the company's Indefinite Delivery Contract (IDC) with the DLA, valued at up to $999,999,999.00 and running through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to provide a comprehensive range of...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $11,132.88 for the pharmaceutical product JANUVIA 100 MG TABLET 90S. The award was made by the Defense Logistics Agency (DLA), a defense agency responsible for providing logistics, acquisition, and technical services to the U.S. military. The contract has an ultimate completion date of June 9, 2023 and is a firm fixed-price delivery order, with no set-aside designation....
This federal contract award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, is a delivery order valued at $6,695.92 for the supply of JANUVIA 100 MG TABLET 90S. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of November 15, 2024. The contract is a firm fixed-price delivery order, and there was no set-aside designation used. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award, valued at $25,746.39, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract is for the delivery of 4558910099 JANUVIA 100 MG TABLET 90S, a pharmaceutical product. It is a firm-fixed price delivery order contract with an ultimate completion date of October 28, 2022. Amerisourcebergen, as a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is for the delivery of JANUVIA 50 MG TABLET 90S to the Defense Logistics Agency (DLA). The $3,100.13 firm-fixed-price delivery order, awarded on April 24, 2023, has an ultimate completion date of April 25, 2023. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen, a major pharmaceutical distributor, holds a significant $999,999,999 Indefinite Delivery...
This federal contract award to AmerisourceBergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order with a ceiling value of $19,716.65. The contract, awarded by the Defense Logistics Agency (DLA) Troop Support Medical, is for the supply of JANUVIA 100 MG TABLET 90S, a pharmaceutical product. The contract has an ultimate completion date of October 12, 2023 and is a firm fixed-price delivery order. The contract is not designated as a set-aside. AmerisourceBergen Drug Corp holds a...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $9,636.30 for the supply of Januvia 100 mg tablets. The contract was awarded by the Defense Logistics Agency (DLA) and has a completion date of March 18, 2022. It is a firm-fixed-price contract, with no set-aside designation, indicating open competition. Amerisourcebergen Drug Corp is a major pharmaceutical distributor that serves as a critical supplier to various federal...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a delivery order valued at $2,335.80 for the supply of 4564361243 JANUVIA 50 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency under the Department of Defense (DoD), and has an ultimate completion date of April 23, 2024. The contract is a firm fixed-price arrangement and does not utilize any set-aside designations, indicating open competition....
  • SPE2DB20D3101
    Indefinite Delivery Contract
  • SPE2DB20D3101-SPE2DB23FRXA5
    Delivery Order

This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc., is a Delivery Order valued at $9,433.75 for the pharmaceutical product JANUVIA 25 MG TABLET 90S. The contract was awarded by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of September 11, 2023.

Amerisourcebergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00 through November 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract does not have a set-aside designation, indicating open competition.

Generated 2/27/25, 12:01 PM